期刊文献+

我国学者积极开展COVID-19防治研究并取得重要成果 被引量:9

Active researches on prevention and treatment of COVID-19 by Chinese scholars with significant results
下载PDF
导出
摘要 目前新型冠状病毒仍在全球蔓延,蔓延速度快,传播性强,传播途径多。2020年1月31日世界卫生组织宣布新型冠状病毒引起的肺炎(COVID-19)疫情为“国际关注的突发公共卫生事件”。截至北京时间2020年5月31日,全球累计确诊COVID-19病例超过621万,累计死亡病例超过37万例。疫情的爆发促进我国医药、卫生预防的研究工作者开展了大量的新冠肺炎研究工作,取得的重要成果在国内外医药期刊发表大量文章。该文通过中国知网,对2020年1月至4月期间我国学者发表在国内医药期刊的新冠肺炎相关的文章进行分析总结。发现刊载COVID-19文章的期刊杂志多而广,研究机构多,包括医院、高校、科研院所和制药企业。研究内容全面,包括发病机制、病毒抗体检测、新冠肺炎诊断、疫情防控策略和疫苗研发、治疗药物研发等。治疗措施多途径,包括抗病毒治疗、提高机体免疫力治疗,既有西药治疗,也有中药调理和中西医结合治疗等。这些研究成果和诊治经验为全球疫情国家防治新冠肺炎提供了重要参考。 At present,novel coronavirus is spreading wordwide,with rapid speed,strong transmissibility and many spreading channels.On January 31,2020,WHO declared the pneumonia(COVID-19)outbreak caused by novel coronavirus to be“an public health emergency of international concern”.As of May 31,2020,Beijing time,the cumulative number of confirmed COVID-19 cases worldwide had exceeded 6.21 million,and the cumulative number of deaths had exceeded 370000.The outbreak of COVID-19 has prompted Chinese medical and health prevention researchers to carry out a large number of studies on COVID-19,and the important achievements have been published in many medical journals at home and abroad.Through CNKI,this study analyzed and summarized COVID-19 related articles published by Chinese scholars in domestic medical journals from January to April 2020.It was found that COVID-19 related articles were published in a wide range of journals and research institutions,including hospitals,universities,research institutes and pharmaceutical companies.The research content is comprehensive,including pathogenesis,virus antibody detection,COVID-19 diagnosis,epidemic prevention and control strategies,vaccine development and treatment drug development,etc.The treatment of COVID-19 is multipath,including anti-virus,improving the body’s immunity,Western medicine treatment,TCM conditioning and integrated treatment of traditional Chinese and Western medicine.These research findings and diagnosis and treatment experience provide important references for the prevention and treatment of COVID-19 around the world.
作者 徐莉 葛瑾茹 张玲玲 魏伟 XU Li;GEN Jin-ru;ZHANG Ling-ling;WEI Wei(Institute of Clinical Pharmacology,Anhui Medical University,Key Lab of Anti-Inflammatory and Immune Medicine,Ministry of Education,Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine,Hefei 230032,China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2021年第3期301-308,共8页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(NoU1803129,81973332)。
关键词 新型冠状病毒 新型冠状病毒肺炎 机制 治疗药物 疫苗研发 研究机构 SARS-COV-2 COVID-19 mechanisms therapeutic drugs vaccine development research institutions
  • 相关文献

参考文献21

二级参考文献136

共引文献2990

同被引文献71

引证文献9

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部